FDA Heard All Stories Of AndroGel Heart Attacks, Jury Told

By Diana Novak Jones (July 19, 2017, 10:11 PM EDT) -- An AbbVie Inc. executive who monitored the safety of the company's products told an Illinois federal jury Wednesday that the U.S. Food and Drug Administration had all the company's information on heart attacks suffered by people on AndroGel but repeatedly declined to ask for a study on the risk....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!